What STEP 2 tells us about maintenance, and what it does not
What the labels permit, what clinicians do, and the size of the gap between them.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 2 of 25 of this archive, newest first.
What the labels permit, what clinicians do, and the size of the gap between them.
Reported from the sessions, and from the two hours afterwards.
Reported from the sessions, and from the two hours afterwards.
Reported from the sessions, and from the two hours afterwards.
Reported from the sessions, and from the two hours afterwards.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
Reported from the sessions, and from the two hours afterwards.
What was withdrawn, from whom, after how long, and what was measured afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
The regain trajectories, arm by arm, with the estimands named.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.